• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,070.32 -546.08
( -0.70%)
Global Indices
Nasdaq
52,524.20 -133.81
(-0.25%)
Dow Jones
7,536.77 -59.62
(-0.78%)
Hang Seng
67,669.68 426.95
(0.63%)
Nikkei 225
10,494.06 -3.23
(-0.03%)
Forex
USD-INR
95.25 -0.20
(-0.21%)
EUR-INR
108.70 -0.40
(-0.37%)
GBP-INR
127.58 -0.36
(-0.28%)
JPY-INR
0.59 0.00
(0.19%)

EQUITY - MARKET SCREENER

Sat Kartar Life Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
93343
INE0NB801022
43.3811704
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SATKARTAR
12.35
213.24
EPS(TTM)
Face Value()
Div & Yield %
10.93
10
0
 

Odyssey Corporation reports consolidated net profit of Rs 2.54 crore in the March 2026 quarter
May 28,2026
Net profit of Odyssey Corporation reported to Rs 2.54 crore in the quarter ended March 2026 as against net loss of Rs 0.30 crore during the previous quarter ended March 2025. Sales rose 63.44% to Rs 21.46 crore in the quarter ended March 2026 as against Rs 13.13 crore during the previous quarter ended March 2025.

For the full year,net profit rose 229.17% to Rs 4.74 crore in the year ended March 2026 as against Rs 1.44 crore during the previous year ended March 2025. Sales rose 74.24% to Rs 49.38 crore in the year ended March 2026 as against Rs 28.34 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales21.4613.13 63 49.3828.34 74
OPM %-17.94-21.86 --12.09-13.51 -
PBDT5.790.07 8171 12.135.36 126
PBT5.64-0.08 LP 11.514.83 138
NP2.54-0.30 LP 4.741.44 229